Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer

Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer

NCT01458717 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Induction Chemotherapy With Gemcitabine and Cisplatin Followed by CCRT for Unresectable Pancreatic Carcinoma

NCT01593475 ·Status: COMPLETED ·Phase: PHASE2

NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer

NCT01521702 ·Status: COMPLETED ·Phase: PHASE3

Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Cancer

NCT05841420 ·Status: RECRUITING ·Phase: PHASE2

A Phase III Study of Pancreatic Cancer

NCT00994721 ·Status: COMPLETED

Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer

NCT02981719 ·Status: COMPLETED ·Phase: NA

An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer

NCT06129812 ·Status: COMPLETED

Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer

NCT01851174 ·Status: TERMINATED ·Phase: PHASE2

Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer

NCT01430052 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Modified Nab-Paclitaxel Plus Gemcitabine Chemotherapy for Metastatic Pancreatic Cancer

NCT03502343 ·Status: UNKNOWN ·Phase: PHASE2

Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer

NCT01314027 ·Status: TERMINATED ·Phase: PHASE3

Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

NCT00058149 ·Status: COMPLETED ·Phase: PHASE3

Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic Cancer

NCT01396681 ·Status: COMPLETED ·Phase: PHASE2

Phase I Study of Neoadjuvant Chemotherapy for Patients With Borderline Resectable Pancreatic Cancer.

NCT02506803 ·Status: UNKNOWN ·Phase: PHASE1

Comparative Study Between Immediate Surgery Versus Neoadjuvant Chemotherapy for Management of Resectable Pancreatic Cancer

NCT06978322 ·Status: COMPLETED

Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas

NCT00003797 ·Status: UNKNOWN ·Phase: PHASE2

Phase 1 Study of Preoperative Gemcitabine Plus CP-870, 893 Followed by Addition of CP-870,893 to Standard -Of-care Adjuvant Chemoradiation for Patients With Newly Diagnosed Resectable Pancreatic Carcinoma

NCT01456585 ·Status: COMPLETED ·Phase: PHASE1

Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas

NCT00005926 ·Status: COMPLETED ·Phase: PHASE2

Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of ERCC1 in Treatment Decision

NCT01188109 ·Status: TERMINATED ·Phase: PHASE2

Neoadjuvant Chemotherapy and Stereotactic Radiosurgery to Pancreatectomy for Patients With Borderline Resectable Pancreatic Cancer

NCT03199144 ·Status: WITHDRAWN ·Phase: PHASE2

GS Regimen as the First-line Chemotherapy in Chinese Advanced PC Patients

NCT03869294 ·Status: COMPLETED

Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer Patients

NCT06234072 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic Cancer

NCT03572400 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy

NCT05415917 ·Status: WITHDRAWN ·Phase: PHASE2

Surgical Results of Resection of Locally Advanced Pancreatic Cancer

NCT06206382 ·Status: NOT_YET_RECRUITING